Clinical Trials Browser

OTHER × Breast Carcinoma In Situ × exemestane × Clear all

NCT06671912 2026-06-02

LoTam

Phase 3 Suspended

Breast Carcinoma In Situ

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms